Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-03

Clinical Trial Update: An Observational Study to Assess Ubrogepant Tablets and Atogepant Tablets to Treat Migraine in Adult Participants

View source ↗

Summary

A completed observational study evaluated the effectiveness of ubrogepant and atogepant tablets for treating migraine in adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atogepant (Atogepant)
  • Ubrogepant (ubrogepant)

Snippet

Sponsor: AbbVie | Conditions: Migraine | Status: COMPLETED